Gift benefits education Salmon: Oncology Luminary Seeing cancer differently The cutting edge

Gift benefits education

A planned estate gift to the University of Arizona will name The Tim and Diane Bowden Cancer Biology Graduate Interdisciplinary Program at the UA Cancer Center, and support Parkinson’s disease research being conducted by Scott J. Sherman, MD, PhD.

Read More

Salmon: Oncology Luminary

University of Arizona Cancer Center founding Director Sydney E. Salmon, MD, has been named an “Oncology Luminary” by the American Society of Clinical Oncology in celebration of its 50th anniversary.

Read More

Seeing cancer differently

Truly groundbreaking cancer research is reserved for those who find new ways to look at the disease. Ghassan Mouneimne, PhD, is doing just that.

Read More

The cutting edge

From genome sequencing to cellular biology to clinical application, the team at the UA Cancer Center approaches its research from all angles to deliver the most forward-thinking, state-of-the-art cancer care.

Read More

Featured Stories

Research study tests weight loss program for female colorectal cancer survivors

S1008 is a clinical trial to test whether an exercise and diet weight loss program can help overweight female colon or rectal cancer survivors reach a healthy body weight. 

Bradley J. Monk, MD, FACOG, FACS

UACC at St. Joseph’s reports promising cervical cancer findings in New England Journal of Medicine

Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph’s Hospital and Medical Center has been published in the New England Journal of Medicine.

Ali McBride, MS, PharmD, BCPS

Ali McBride, PharmD, MS, BCPS, named UACC clinical coordinator

The University of Arizona Cancer Center has named Ali McBride, PharmD, MS, BCPS, clinical coordinator, where he will collaborate with the director of pharmacy, oncology services and other members of the healthcare team to improve the services delivered by the oncology pharmacy team.

H-H. Sherry Chow, PhD

Study looks at cancer preventative effects of anti-diabetic drug

A $2.8 million grant will fund a study to determine the cancer risk reduction effects of Metformin in overweight and obese premenopausal women.


Thu, 04/24/2014 - 9:00am - 12:00pm
Thu, 04/24/2014 - 1:00pm - 5:00pm
Thu, 04/24/2014 - 2:30pm - 4:00pm
Thu, 04/24/2014 - 5:30pm - 7:00pm
Fri, 04/25/2014 - 8:00am - 12:00pm

Sign up for the UACC's monthly E-Newsletter